• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Hilco Vision’s Las Vegas facility receives National Association of Boards of Pharmacy (NABP) Drug Distributor Accreditation

Article

This certifies that the facility adheres to a comprehensive set of regulatory standards as set by the NABP to ensure safety of drugs and medical devices in the US.

a photo of the welcome to las vegas sign with the skyline in the background. (Image Credit: AdobeStock/somchaij)

(Image Credit: AdobeStock/somchaij)

The NABP Drug Distributor Accreditation is a resource for industry and regulatory bodies that establish uniform safeguards meant to protect the public health. This distinction plays a pivotal role in preventing counterfeit drugs from entering the United States drug supply and protects the public from drugs that have been contaminated, diverted, or counterfeited. This accreditation process required Hilco Vision to demonstrate compliance to a comprehensive set of regulatory standards and best practices in safely distributing prescription drugs from manufacturers to pharmacies and other institutions.

“It is more important than ever to strive for the highest standards of compliance in pharmaceutical distribution. This accreditation for our Nevada facility demonstrates our commitment to continuous improvement in supply chain on behalf of our customers,” says Ross Brownlee, CEO of Hilco Vision in the company’s news release.

NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh shared how this accreditation of Hilco’s Las Vegas facility is key to public health. In the press release, he said, “NABP congratulates Hilco Vision on achieving this important recognition. By earning the Drug Distributor Accreditation, they demonstrate their commitment to preventing counterfeit drugs from entering the US drug supply, and they hold a pivotal role in protecting the public health.”

Reference:
Hilco Vision Earns NABP Drug Distributor Accreditation. Hilco Vision. July 10, 2023. Accessed July 11, 2023. https://news.hilcovision.com/2023/07/hilco-vision-earns-nabp-drug-distributor-accreditation/
Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
© 2024 MJH Life Sciences

All rights reserved.